Blood Glucose Test Strips - Medical Devices Pipeline Assessment, 2019

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Blood Glucose Test Strips Overview

3 Products under Development

• 3.1 Blood Glucose Test Strips - Pipeline Products by Stage of Development
• 3.2 Blood Glucose Test Strips - Pipeline Products by Territory
• 3.3 Blood Glucose Test Strips - Pipeline Products by Regulatory Path
• 3.4 Blood Glucose Test Strips - Pipeline Products by Estimated Approval Date

4 Blood Glucose Test Strips - Pipeline Products under Development by Companies

• 4.1 Blood Glucose Test Strips Companies - Pipeline Products by Stage of Development
• 4.2 Blood Glucose Test Strips - Pipeline Products by Stage of Development

5 Blood Glucose Test Strips Companies and Product Overview

• 5.1 Accessible Diagnostics LLC Company Overview
• 5.2 Achira Labs Pvt Ltd Company Overview
• 5.3 DirectSens GmbH Company Overview
• 5.4 Gluco-Chaser Inc Company Overview
• 5.5 PharmaTech Solutions Inc Company Overview

6 Blood Glucose Test Strips- Recent Developments

• 6.1 Jun 11, 2019: Changes in Roche's board of directors and corporate executive committee
• 6.2 Jun 11, 2019: Regulators demand more details on Roche’s $4.8bn Spark acquisition
• 6.3 May 28, 2019: LifeScan names Alisandra Rizzolo Head of Transformation
• 6.4 May 22, 2019: Serving the needs of the medical front and creating new value the start of a New Medical Device and Reagent Brand: "The Lab"
• 6.5 May 20, 2019: LifeScan Names Ty Lee Head of Marketing
• 6.6 May 09, 2019: Senseonics Holdings reports first quarter 2019 financial results
• 6.7 May 09, 2019: DECN sets plan to make upcoming patent infringement appeal hearing and mediation with Johnson & Johnson a foundation for substantial recovery
• 6.8 Apr 26, 2019: Nationally recognized expert in consumerism joins Henry Ford Health System
• 6.9 Apr 23, 2019: In Prelude to probable transaction DECN decides to infuse its outre' precise, TBG technology to its GenChoice Test Strip, now in FDA 510k review
• 6.10 Apr 23, 2019: Universal Biosensors: Commentary on Q1 2019 appendix 4C cash flow summary
• 6.11 Apr 17, 2019: DECN expands talks involving its GenUltimate TBG System, balances potential and competing outcomes with recent intro to 2nd interested party
• 6.12 Apr 17, 2019: Roche reports a strong start in 2019 and raises the outlook for the full-year
• 6.13 Apr 17, 2019: Abbott reports first-quarter 2019 results
• 6.14 Apr 09, 2019: Henry Ford Health System names two new senior leaders
• 6.15 Apr 08, 2019: LifeScan names Brian Heald as its new Head of Product
• 6.16 Apr 01, 2019: Mologic expands US and UK operations
• 6.17 Mar 21, 2019: Roche sues U.S. executives in fight over diabetes test strips
• 6.18 Mar 19, 2019: Abbott introduces new digital service in India as part of its global a: care program
• 6.19 Mar 13, 2019: EKF Diagnostics Holdings: Final results
• 6.20 Mar 08, 2019: Universal Biosensors announces resignation of CEO Rick Legleiter
• 6.21 Mar 06, 2019: Senseonics Holdings appoints Francine R. Kaufman, M.D. as chief medical officer
• 6.22 Feb 22, 2019: Abbott planning $62M expansion in Columbus, adding 38 jobs
• 6.23 Feb 05, 2019: Confluent Medical Technologies launches the high-performance nitinol tubing center of excellence
• 6.24 Jan 31, 2019: Roche reports very strong results in 2018
• 6.25 Jan 30, 2019: DECN subsidiary receives 510k submission and ''K'' numbers from FDA CDRH for Its Genchoice! Test Strip at the close of the government shutdown
• 6.26 Jan 29, 2019: Universal Biosensors: Commentary on FY 2018
• 6.27 Jan 24, 2019: Genentech announces Alexander Hardy as Chief Executive Officer
• 6.28 Jan 23, 2019: Abbott reports 2018 results and issues strong forecast for 2019
• 6.29 Jan 21, 2019: ARKRAY USA launches Assure Slide swallowing aid
• 6.30 Jan 10, 2019: ARKRAY Commences Overseas Remote Maintenance Services for Medical Devices
• 6.31 Jan 09, 2019: STANDARD GlucoNavii GDH now available for newborn testing
• 6.32 Jan 07, 2019: Senseonics Holdings names Jon D. Isaacson as chief financial officer
• 6.33 Jan 02, 2019: Roche Diabetes Care India appoints Dr. Gaurav Laroia as general manager
• 6.34 Dec 20, 2018: Strengthening Global Research and Development Networks AI Software Development facility established in India
• 6.35 Dec 20, 2018: Universal Biosensors provides business update
• 6.36 Dec 19, 2018: DECN Subsidiaries Appeal Nevada District Court Trial Judge's Ruling to U.S. Court of Appeals for the Federal Circuit (The Patent Appeals Court)
• 6.37 Dec 17, 2018: DECN Engages second Korean manufacturing partner to raise its factory capacity by two million boxes of ''GEN'' test strips annually
• 6.38 Dec 10, 2018: New member proposed for election to Roche Board of Directors
• 6.39 Dec 10, 2018: ARKRAY USA changes name of long-term care division to professional healthcare division
• 6.40 Dec 10, 2018: Roche names William Anderson as CEO
• 6.41 Dec 10, 2018: Roche names William Bill Anderson as CEO from January 01 2019
• 6.42 Dec 04, 2018: DECN receives completed clinical trials report from its IRB and anticipates filing its U.S. FDA 510k application for its Genchoice! product
• 6.43 Dec 04, 2018: ARKRAY expands to its 13th Country with a new branch in Dubai
• 6.44 Dec 03, 2018: Senseonics Holdings announces retirement of Chief Financial Officer
• 6.45 Dec 03, 2018: Roche to increase its payroll in Switzerland by 1.2 percent
• 6.46 Nov 26, 2018: Henry Ford Health System announced Dr. Betty Chu appointments
• 6.47 Nov 08, 2018: Senseonics Holdings reports third quarter 2018 financial results
• 6.48 Nov 07, 2018: LifeScan unveils new name and branding for the LifeScan Diabetes Institute
• 6.49 Nov 06, 2018: DECN receives completed clinical trial data, charts and spreadsheets essential for its imminent Genchoice! Test Strip
• 6.50 Oct 30, 2018: Universal Biosensors releases Q3 FY2018 results
• 6.51 Oct 17, 2018: Roche reports very strong growth in the first nine months of 2018
• 6.52 Oct 17, 2018: Roche reports sales growth as new drugs ease pressure from biosimilar competition
• 6.53 Oct 17, 2018: Abbott Reports Third-Quarter 2018 Results
• 6.54 Oct 15, 2018: Abbott names Robert B. Ford President, Chief Operating Officer
• 6.55 Oct 03, 2018: J&J concludes sale of LifeScan to Platinum Equity for $2.1bn
• 6.56 Sep 19, 2018: EKF Diagnostics: Half yearly report
• 6.57 Sep 13, 2018: Roche ranked the most sustainable healthcare company in the Dow Jones Sustainability Indices for the tenth year running
• 6.58 Sep 13, 2018: Abbott is named global industry leader in sustainability for the sixth consecutive year on the Dow Jones Sustainability Index (DJSI)
• 6.59 Aug 24, 2018: Cadila Healthcare’s Biologics manufacturing facility successfully completes USFDA inspection
• 6.60 Aug 14, 2018: DECN announces significant updates for products and programs
• 6.61 Aug 14, 2018: DECN Announces Significant Updates For Products And Programs
• 6.62 Aug 08, 2018: Senseonics Holdings reports second quarter 2018 financial results
• 6.63 Aug 01, 2018: Global Healthcare Organizations join Abbott to launch the UNIVANTS of Healthcare Excellence Award
• 6.64 Jul 26, 2018: Roche reports very strong performance in the first half of 2018
• 6.65 Jul 19, 2018: Universal Biosensors Announces Q2 Appendix 4C Cash F low Summary
• 6.66 Jul 18, 2018: Abbott reports second-Quarter 2018 Results

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us